Close Menu

This article has been updated to reflect further commentary made by the company.

NEW YORK (GenomeWeb) – Last month, iCareDx announced that it was rebranding itself as Acuamark Diagnostics as it works to raise funds for its first round of clinical testing.

"It is a more precise reflection of what we are doing," Acuamark President and CEO Bernard Peperstraete told GenomeWeb. "Acua is also a play on accurate and liquid, and Acuamark — or watermark — reflects that each cancer leaves a barely visible imprint, and needs to be looked at in a different light."

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.